BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 16644117)

  • 1. Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on BDNF mRNA expression in rat frontal cortex and hippocampus.
    Martínez-Turrillas R; Moyano S; Del Río J; Frechilla D
    Neurosci Lett; 2006 Jul; 402(1-2):126-30. PubMed ID: 16644117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rat frontal cortex but not in the hippocampus.
    García-Osta A; Del Río J; Frechilla D
    Brain Res Mol Brain Res; 2004 Jul; 126(2):181-7. PubMed ID: 15249142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat.
    Jacobsen JP; Mørk A
    Brain Res; 2006 Sep; 1110(1):221-5. PubMed ID: 16876769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated BDNF protein level in cortex but not in hippocampus of MDMA-treated Dark Agouti rats: a potential link to the long-term recovery of serotonergic axons.
    Adori C; Andó RD; Ferrington L; Szekeres M; Vas S; Kelly PA; Hunyady L; Bagdy G
    Neurosci Lett; 2010 Jul; 478(2):56-60. PubMed ID: 20435092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels.
    Jacobsen JP; Mørk A
    Brain Res; 2004 Oct; 1024(1-2):183-92. PubMed ID: 15451381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single dose of MDMA causes extensive decrement of serotoninergic fibre density without blockage of the fast axonal transport in Dark Agouti rat brain and spinal cord.
    Kovács GG; Andó RD; Adori C; Kirilly E; Benedek A; Palkovits M; Bagdy G
    Neuropathol Appl Neurobiol; 2007 Apr; 33(2):193-203. PubMed ID: 17359360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
    Kirilly E
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation between serotonin neurotoxicity and brain-derived neurotrophic factor induction following neonatal MDMA exposure in rats.
    Piper BJ; Farelli JD; Meyer JS
    Dev Neurosci; 2009; 31(1-2):90-4. PubMed ID: 19372690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns.
    Adori C; Andó RD; Kovács GG; Bagdy G
    J Comp Neurol; 2006 Jul; 497(2):251-69. PubMed ID: 16705678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants.
    Larsen MH; Hay-Schmidt A; Rønn LC; Mikkelsen JD
    Eur J Pharmacol; 2008 Jan; 578(2-3):114-22. PubMed ID: 17950272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A preliminary study on the mechanism of neurotoxicity of MDMA--oxidative stress harm].
    Li SX; Sun AM; Wang X; Li J; Peng ZG; Kuang WH; Huang MS
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):191-5. PubMed ID: 16608072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered gene expression in frontal cortex and midbrain of 3,4-methylenedioxymethamphetamine (MDMA) treated mice: differential regulation of GABA transporter subtypes.
    Peng W; Simantov R
    J Neurosci Res; 2003 Apr; 72(2):250-8. PubMed ID: 12672000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat.
    Koprich JB; Campbell NG; Lipton JW
    Brain Res Dev Brain Res; 2003 Dec; 147(1-2):177-82. PubMed ID: 14741762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of BDNF and TrkB expression in rat hippocampus in response to acute neurotoxicity by diethyldithiocarbamate.
    Micheli MR; Bova R; Laurenzi MA; Bazzucchi M; Grassi Zucconi G
    Neurosci Lett; 2006 Dec; 410(1):66-70. PubMed ID: 17052849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
    Sprague JE; Nichols DE
    J Pharmacol Exp Ther; 1995 May; 273(2):667-73. PubMed ID: 7538579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3,4-Methylenedioxymethamphetamine increases pro-interleukin-1beta production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: role of interleukin-1beta in neurotoxicity.
    O'Shea E; Sanchez V; Orio L; Escobedo I; Green AR; Colado MI
    Neuroscience; 2005; 135(4):1095-105. PubMed ID: 16165281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
    Yeh SY
    Synapse; 1999 Mar; 31(3):169-77. PubMed ID: 10029234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.